PHK
MRNS

Point72 Hong Kong’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Point72 Hong Kong’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-848
Closed -$11K – 2110
2020
Q3 		$11K Buy
+848
New +$7.32K ﹤0.01% 980
2020
Q1 		– Sell
-2,498
Closed -$22K – 1450
2019
Q4 		$22K Buy
+2,498
New +$14K 0.01% 868
2019
Q1 		– Sell
-3,099
Closed -$36K – 1343
2018
Q4 		$36K Buy
+3,099
New +$62.7K 0.02% 367

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Point72 Hong Kong's MRNS Position: Q4 2020 in Review

Point72 Hong Kong sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2020, closing a stake of 848 shares — an estimated $11K sold.

Point72 Hong Kong first reported a position in MRNS in Q4 2018 and held it in 3 quarters. The position peaked at $36K in Q4 2018. 88 funds tracked by Wall St. Rank hold MRNS as of Q4 2020.

  • Point72 Hong Kong reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 848 Marinus Pharmaceuticals, Inc shares in Q4 2020, an estimated $11K.
  • Point72 Hong Kong first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 3 quarters.
  • Point72 Hong Kong's Marinus Pharmaceuticals, Inc position peaked at $36K in Q4 2018.
  • 88 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2020.

Based on Point72 Hong Kong's 13F filing for Q4 2020, filed 16 Feb 2021.